Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis

References

• Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis of microspheres. J Control Release, 79, 29–40.
   PubMed Web of Science ®Google Scholar
• Almawi WY, Melemedjian OK. (2002). Negative regulation of nuclear factor-kB activation and function by glucocorticoids. J of Mol Endocrinology, 28, 69–78.
   PubMed Web of Science ®Google Scholar
• Bejugam NK, Uddin AN, Gayakwad SG, D’Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25, 577–583.
   PubMed Web of Science ®Google Scholar
• Cetinkaya RA, Görenek L, Coskun O, Eyigün CP, Senses Z, Ide T, Kiliç S. (2009). The effect of methylprednisolone on treatment in rats with induced sepsis. Clin Exp Med, 9, 45–50.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Premachandran S, Shukla J, Poduval TB. (2007). Synergistic therapeutic and L-arginine in lipopolysaccharide-induced septic shock. J Surgical Res 140, 99–108.
   PubMed Web of Science ®Google Scholar
• Crinelli R, Antonelli A, Bianchi M, Gentilini L, Scaramucci S, Magnani M. (2000). Selective inhibition of NF-κB activation and TNF-a production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells, Molecules and Diseases 26, 211–222.
   PubMed Web of Science ®Google Scholar
• D’Acquisto F, May MJ, Ghosh S. (2002). Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv, 2, 22–35.
   PubMedGoogle Scholar
• D’Souza MJ, Jin Z, Oettinger CW. (2005). Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-κB. J Interferon Cytokine Res, 25, 311–320.
   PubMed Web of Science ®Google Scholar
• D’Souza MJ, Oettinger CW, Milton GV. (1999a). Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. J Interferon Cytokine Res, 19, 1125–1133.
   PubMed Web of Science ®Google Scholar
• D’Souza MJ, Oettinger CW, Milton GV. (2000). Microspheres containing neutralizing antibodies to tumor necrosis factor–α and interleukin-1β protect rats from staphlococcus aureus-induced peritonitis. J Interferon Cytokine Res, 20, 907–913.
   PubMed Web of Science ®Google Scholar
• D’Souza MJ, Oettinger CW, Shah A, Tipping PG, Huang XR, Milton GV. (1999b). Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis. Drug Dev Ind Pharm, 25, 591–596.
   PubMed Web of Science ®Google Scholar
• De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. (1997). Glucocorticoid-mediated repression of nuclear factor-kB-dependent transcription involves direct interference with transactivation. Proc Natl Acad of Sci, 94, 13504–13509.
   PubMed Web of Science ®Google Scholar
• Dellinger RP. (2008). Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med, 36, 296–327.
   PubMed Web of Science ®Google Scholar
• Finfer S. (2008). Corticosteroids in septic shock. N Engl J Med, 358, 188–190.
   PubMed Web of Science ®Google Scholar
• Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D’Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. J Microencapsul, 15, 1–9.
   Google Scholar
• Hayashi R, Wada H, Ito K, Adcock IM. (2004). Effects of glucocorticoids on gene transcription. Eur J Pharmacol, 500, 51–62.
   PubMed Web of Science ®Google Scholar
• Kwame GY, D’Souza MJ. (2009). Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines. Journal of Microencapsulation, 26, 166–179.
   PubMed Web of Science ®Google Scholar
• Makino K, Yamamoto N, Higuchi K, Harada N, Ohshima H, Terada H. (2003). Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of size and surface properties of the microspheres. Colloids and Surfaces B: Biointerfaces, 27, 33–39.
   Web of Science ®Google Scholar
• Malvern Instruments Ltd. (2011). Zeta potential - An introduction in 30 minutes (KB000734). Available at http://www.malvern.com.
   Google Scholar
• Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. (2004). Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med, 141, 47–56.
   PubMed Web of Science ®Google Scholar
• Neeck G, Renkawitz R, Eggert M. (2002). Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis. Cytokines Cell Mol Ther, 7, 61–69.
   PubMed Web of Science ®Google Scholar
• Nissen RM, Yamamoto KR. (2000). The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev, 14, 2314–2329.
   PubMed Web of Science ®Google Scholar
• Oettinger C, D’Souza M. (2003). Microencapsulation of tumor necrosis factor oligomers: a new approach ton proinflammatory cytokine inhibition. J Interferon Cytokine Res, 23, 533–543.
   PubMed Web of Science ®Google Scholar
• Oettinger CW, D’Souza MJ, Akhavein N, Peer GT, Taylor GT, Kinasewitz GT. (2007). Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense to NF-κB. J Microencapsul, 24, 337–348.
   PubMed Web of Science ®Google Scholar
• Oettinger CW, D’Souza M, Milton GV. (1999). Targeting macrophages with microspheres containing cytokine-neutralizing antibodies prevents lethality in gram negative peritonitis. J Interferon Cytokine Res, 19, 33–40.
   PubMed Web of Science ®Google Scholar
• Oliver JC, Bland LA, Oettinger CW, Arduino MJ, McAllister SK, Aguero SM, Favero MS. (1993). Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res, 12, 115–120.
   PubMedGoogle Scholar
• Reinhart K, Waheedullah K. (2001). Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned 29, 121–125.
   Google Scholar
• Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. (1995). Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol and Cell Biol, 15, 943–953.
   PubMed Web of Science ®Google Scholar
• Silva AT, Bayston KF, Cohen J. (1990). Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis, 162, 421–427.
   PubMed Web of Science ®Google Scholar
• Siwale RC, Oettinger CW, Addo R, Siddiq A, D’Souza MJ. (2009a). The effect of intracellular delivery of catalase and antisense oligonucleotides to NF-κB using albumin microcapsules in the endotoxic shock model. J Drug Target, 17, 701–709.
   PubMed Web of Science ®Google Scholar
• Siwale RC, Oettinger CW, Balakrishna P, Addo R, Uddin N, Siddig A, D’Souza MJ. (2008). Formulation and characterization of catalase in albumin microspheres. J Microencapsul, 23, 1–9.
   Google Scholar
• Siwale RC, Yeboah GK, Addo R, Oettinger CW, D’Souza MJ. (2009b). The effect of intracellular antioxidant delivery (catalase) in hydrogen peroxide and proinflammatory cytokine synthesis: a new therapeutic horizon. J Drug Target, 17, 710–718.
   PubMed Web of Science ®Google Scholar
• Song HL, Lv S, Liu P. (2009). The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure. BMC Gastroenterol, 9, 70.
   PubMedGoogle Scholar
• Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group. (2008). Hydrocortisone therapy for patients with septic shock. N Engl J Med, 358, 111–124.
   PubMed Web of Science ®Google Scholar
• Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, Hylton DM, Rudge JS, Liu-Bryan R, Terkeltaub RA, Yancopoulos GD, Murphy AJ. (2009). Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis, 68, 1602–1608.
   PubMed Web of Science ®Google Scholar
• Tracey KJ, Lowry SF, Fahey TJ, Albert JD, Fong Y, Hesse D, Buetler B, Manogue KR, Calvano S, Wei H, Cerami A. (1987). Cachetin/tumor necrosis factor induces lethal shock and stress hormone response in the dog. Surgery, Gynecology and Obstetrics, 164, 415–422.
   PubMedGoogle Scholar
• Tsao PW, Suzuki T, Totsuka R, Murata T, Takagi T, Ohmachi Y, Fujimura H, Takata I. (1997). The effect of dexamethasone on the expression of activated NF-κB in adjuvant arthritis. Clin Immun and Immunopathology, 83, 173–178.
   PubMedGoogle Scholar
• Uddin MN, Do DP, Pai SB, Gayakwad S, Oettinger CW, D’Souza MJ. (2009). A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. Analyst, 134, 1483–1489.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Fukai F, Ohshima H, Terada H, Makino K. (2002). Dependence of phagocytic uptake of polystyrene microspheres by differentiated HL60 upon the size and surface properties of the microspheres. Colloids and Surfaces B: Biointerfaces, 25, 157–162.
   Web of Science ®Google Scholar
• Zhaowei J, D’Souza MJ, Oettinger CW. (2007). Reversal of LPS induced endothelial cell TNF synthesis and increased permeability with microencapsulated antisense oligomers to NF-κB. J Microencapsul, 24, 596–607.
   PubMed Web of Science ®Google Scholar